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Abstract 31 
Objective: Our objective was to clarify whether de novo urinary incontinence (UI) in the 32 
postpartum period is associated with depressive symptoms or antidepressant drug consumption. 33 
Study Design: 2002 pregnant women were recruited between 2003 and 2006 for the EDEN 34 
mother–child cohort. This analysis included 1413 women who reported no UI before pregnancy. 35 
Severity of UI was assessed by the Sandvik index. At 4 and 12 months postpartum, depressive 36 
symptoms were assessed by the Edinburgh Postpartum Depression Scale (EPDS ≥ 10 defines 37 
depressive symptoms) and consumption of antidepressant drugs was reported.  38 
Results: At 4 months postpartum, 198 women (14%) reported de novo UI; 74% (n=146) reported 39 
mild UI, 26% (n=52) moderate, and none severe; prevalence of depressive symptoms was higher in 40 
women with than without UI (22.1% vs. 15.9%, p=0.045), and consumption of antidepressant 41 
drugs was more frequent (4.7% vs. 1.4%, p=0.005). At 12 months postpartum, the mean (±SD) 42 
EPDS score differed between women with than without UI (7.30 ±3.46 vs. 6.57 ±3.72, p=0.016) 43 
but was half that at 4 months postpartum. The incidence of new cases of depressive symptoms or 44 
antidepressant consumption at 12 months was greater with than without UI (23.8% vs. 15.3%, 45 
p=0.012).  46 
Conclusions: Although UI is mild in most cases at 4 months postpartum, it is followed by more 47 
new cases of depressive symptoms or antidepressant consumption at 12 months. 48 
Key words: postnatal depression, antidepressant consumption, postpartum care, urinary 49 
incontinence, cohort study 50 
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4 
Introduction 52 
Urinary incontinence (UI) is a common symptom after childbirth (1). Most often postnatal UI is 53 
moderate and regresses after a few months (2). However, it can also persist and lead to deteriorated 54 
quality of life and requests for care later in life (3,4). Fear of postnatal UI can motivate women or 55 
obstetricians to request elective caesarean section even without a medical indication (5).  56 
The postnatal period is also a period susceptible to depressive symptoms, sometimes severe, that 57 
could impair the relationship between the mother and her baby or even lead to suicide (6). In the 58 
general population, women with UI may be more depressed than others (7). Postnatal UI appearing 59 
de novo in women who were continent before pregnancy may induce or increase a depressive 60 
syndrome. The few studies of the postnatal period show that postnatal UI is associated with 61 
depressive symptoms (8,9). However, these investigations did not determine a causal link between 62 
the two situations.  63 
A priori, risk factors of postnatal UI and those of postpartum depression differ. The main risk 64 
factors for postnatal UI are obesity, maternal age, and vaginal childbirth. Muscle and neurological 65 
vaginal birth trauma could explain the postnatal UI (10). The main risk factors for postnatal 66 
depression are personal or family history of depression, stressful life events, low partner support, or 67 
social isolation (11,12).  68 
We aimed to test whether de novo postpartum UI is related to altered mood or taking psychotropic 69 
drugs and whether this association is maintained or increases over time.  70 
71 
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Materials and methods 72 
The data were derived from the EDEN cohort (Etude sur les Déterminants pré et postnatals 73 
précoces du développement psychomoteur et de la santé de l’ENfant, 74 
https://eden.vjf.inserm.fr/index.php?lang=en), whose aim was to study the pre- and postnatal 75 
determinants of child development and health. Study participation was proposed to all women 76 
visiting the prenatal clinic before their 24th week of pregnancy in the university hospitals of Nancy 77 
and Poitiers, our aim was to recruit women as early in pregnancy as possible.
13
 Exclusion criteria 78 
were multiple pregnancies, known diabetes before pregnancy, French illiteracy or planning to move 79 
out of the region within the next three years. Among the 3758 women invited to participate, 2002 80 
(53%) accepted to be enrolled in the study. Recruitment started in February 2003 and lasted 27 81 
months in each centre (1034 women from Nancy and 968 from Poitiers). On average, women were 82 
included at 15 weeks of pregnancy (range: 8-26). Their mean age was 29 years (range: 18-44) and 83 
30% of the women were pregnant for the first time. Compared to the 2003 Enquête Nationale 84 
Périnatale (National Perinatal Survey: a sample of births recruited throughout the country),
14
 85 
women included in EDEN and still followed-up at delivery, had a higher level of education.  86 
To be included in this secondary analysis, the women had to complete a questionnaire about UI 87 
mailed 4 months after childbirth and declare that they did not have UI before the pregnancy. UI 4 88 
months after birth was defined by a positive response to the question "during the past month have 89 
you had involuntary leaking of urine?" The severity of incontinence was assessed by the Sandvik 90 
severity index (15). This index is the product of the frequency and volume of leaks, ranging from 0 91 
to 8. Four classes are defined for UI severity: 0, no incontinence; 1–2, mild incontinence; 3–4, 92 
moderate incontinence; 6–8, severe incontinence.  93 
Depressive symptoms was assessed by questionnaires mailed 4 and 12 months postpartum by 2 94 
indicators. The first, the Edinburgh Postpartum Depression Scale (EPDS), is a 10-item 95 
questionnaire, responses to each item ranging from 0 to 3 (16). The overall score ranges from 0 to 96 
30; a score of 10 or higher defining probable depression. The second relates to the consumption of 97 
antidepressant drugs in the month preceding the mailed questionnaire.  98 
6 
Anthropometric and socio-demographic characteristics were maternal age at delivery grouped into 99 
4 classes: < 25 years, 25–29, 30–34, ≥ 35 years; educational level in 4 classes: below high school 100 
diploma, high school diploma or equivalent, first university degree, above first university degree; 101 
occupational group in 5 classes: 1) managers or professionals; 2) middle management; 3) office or 102 
clerical workers and civil servants; 4) other employees in shops or services, farmers, and workers; 103 
5) no paid occupation; marital status: married, part of an unmarried couple, or single; and body 104 
mass index (BMI). Tobacco use in pregnancy and at 4 months postpartum was described in 105 
dichotomic variables as smokers or non-smokers. For obstetric history, we retained the number of 106 
deliveries and their mode (caesarean delivery only, at least one vaginal delivery); history of birth of 107 
a baby weighing ≥ 4 kg; and for the last delivery, mode of delivery (caesarean, vaginal 108 
spontaneous, vaginal instrumental) and active second phase more than 30 min. Breastfeeding was 109 
considered in 4 modalities: no breastfeeding, ≤ 10 weeks, 11 to 17 weeks and still breastfeeding at 110 
4 months at completion of the questionnaire. 111 
UI was described by its incidence. Risk factors were studied by bivariate analysis of the relation of 112 
obstetric and socio-demographic data and UI (no, mild, moderate) by chi-square test. The relation 113 
between de novo UI and postpartum depressive symptoms was studied by comparing the 114 
proportion of depressed women and women consuming antidepressant drugs at 4 and 12 months. 115 
We also studied new cases of depressive symptoms at 12 months after excluding cases reporting 116 
depressive symptoms at 4 months. The mean change in EPDS score between months 4 and 12 117 
postpartum was compared for women with and without de novo UI at 4 months; we also analysed 118 
new cases of consumption of antidepressant drugs. Then to evaluate the relation between UI and 119 
several risk factors simultaneously, multivariate analysis was performed by polytomic logistic 120 
regression; only variables with p<0.20 on bivariate analysis were introduced in the multivariate 121 
model, except for centre and mode of delivery which were forced in the multivariate model. A last 122 
analysis restricted to women respondent to follow-up questionnaires (4 and 12 months) was 123 
undergone to evaluate the relationship between UI and depressive symptoms or antidepressant 124 
consumption, we used chi-square test for nominal variables and t test for continuous variables; 125 
7 
adjusted OR for age, occupational group, marital status, parity, and centre were estimated using a 126 
logistic regression. 127 
Data were analysed with SAS 9.3 (SAS Inst., Cary, NC). P<0.05 was considered statistically 128 
significant. 129 
The EDEN study received approval from the ethics committee (CCPPRB, Comité Consultatif de 130 
Protection des Personnes en matière de Recherche Biomédicale) of Kremlin-Bicêtre Hospital on 131 
December 12th, 2002. Informed written consent was obtained from mothers for herself at 132 
enrolment and for her newborn child after delivery. The data files were registered with the French 133 
Data Authority (CNIL, Commission Nationale Informatique et Libertés).  134 
 135 
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Results  136 
Among the 2002 women recruited during pregnancy, 1413 (71%; mean age 29.5 years ±4.7, range 137 
17–44 years) were included in this analysis; 353 women who had not responded to questions about 138 
UI and 236 who reported UI before pregnancy were excluded. Included women were older, with a 139 
higher educational level, were more often in couple, and had a lower parity than excluded women 140 
(Supplementary Table S1). In total, 14% (n=198) declared de novo UI at 4 months postpartum; 141 
74% (n=146) were mild, 26% (n=52) moderate, and none severe UI. The incontinence was related 142 
to stress only (leakage during physical effort, coughing, or sneezing) for 37% (n=74), urge only 143 
(leakage related to an urgent need to urinate) for 9% (n=18), mixed (stress and urge) for 47% 144 
(n=93) and other 7% (n=13). Table 1 shows the frequency of the postpartum urinary incontinence 145 
and its severity by medical and socio-demographic characteristics. Moreover, the frequency of UI 146 
and its severity were not at all related to smoking during pregnancy neither at 4 months postpartum. 147 
In the multivariate model of UI (no, mild, moderate), factors contributing to UI were the 148 
occupational group, with the lowest risk among the more qualified occupations and a higher risk of 149 
moderate incontinence among women without a paid job, as well as duration of the second active 150 
phase of the last delivery, with a higher risk among women with a second phase of labour ≥ 30 min 151 
(Table 2).  152 
At 4 months postpartum, 17.8% (215/1210) of women reported depressive symptoms (EPDS ≥ 10) 153 
or used antidepressants. The prevalence of depressive symptoms or antidepressant consumption 154 
was higher for women with than without de novo postpartum UI (Table 3). With a more severe 155 
definition of depression, the difference was still significant: the proportion of women with EPDS ≥ 156 
13 or using antidepressants was higher among women with UI than among women without UI 157 
(14.4% vs 8.7%, p=0.02). 158 
Among the 1413 women included in the analysis, 177 did not respond at 12 months postpartum; 159 
12-month respondents were older, with a higher educational level, and were more often in couple 160 
(Supplementary Table S2). At 1 year postpartum, the mean EPDS score remained higher for 161 
women with than without UI, but the difference was reduced by half between 4 and 12 months 162 
9 
postpartum (1.41 vs 0.73; Table 3). At 1 year postpartum, they were no more significant difference 163 
for depression or antidepressant consumption between women with and without de novo 164 
postpartum UI when the analysis was adjusted for age, occupational group, marital status, parity, 165 
and centre (Table 3). New cases of depressive symptoms or antidepressant consumption at 12 166 
months were more frequent in women with than without UI at 4 months postpartum (Table 3). At 4 167 
months postpartum, depressive symptoms or antidepressant consumption was more often reported 168 
in case of urge UI (50%, 7/14) than in case of mixed UI (32%, 26/81) or stress UI (15%, 10/67; 169 
analysis restricted to women respondent to both questionnaires, chi-square test, p=0.007). At 12 170 
months postpartum we didn’t find any difference related to UI type: depressive symptoms or 171 
antidepressant consumption was reported by 7%  in case of urge UI (1/14), 36% in case of mixed 172 
UI (29/81), 24% in case of stress UI (16/67); and 20% (2/10) in case of other UI (p=0.095). 173 
174 
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Comment 175 
In our sample, UI at 4 months postpartum was often mild and was associated with an increased 176 
postpartum depression screening score and frequent consumption of antidepressant drugs. Follow-177 
up at 1 year postpartum demonstrated that postnatal UI was associated with an increased number of 178 
new cases of depressive symptoms or increased consumption of antidepressants. At 1 year 179 
postpartum, the mean screening depression score differed between women with than without 180 
postnatal UI, but the difference was reduced by half as compared with 4 months postpartum.  181 
The strengths of our study are its longitudinal follow-up and the large number of women included. 182 
We use a standardised measure of UI that incorporates assessment of symptom severity, and a 183 
measurement of depressive symptoms at 2 time points in the first 12 months postpartum using a 184 
well-validated measure. With successive questionnaires, the EDEN cohort allows an exploration of 185 
the temporal relationship between UI and postnatal depression. One limitation is that urinary 186 
symptoms and incontinence history were reported at four months postpartum and not before. This 187 
may explain why only 236 women reported incontinence prior to pregnancy. Another limitation is 188 
the secondary and exploratory nature of this analysis, which did not allow for calculating a number 189 
of subjects required. The questionnaire for UI was not repeated at 12 months; therefore, the effect 190 
of postnatal depression on incident UI was not explored. Likewise, we could not specify whether 191 
the decrease observed between 4 and 12 months postpartum for the relation between UI and the 192 
depression score is associated with decreasing UI prevalence. Another limitation is that depressed 193 
women may over report UI condition. To examine this potential bias we performed an analysis 194 
limited to women without depressive symptoms at the time of UI assessment (4 months 195 
postpartum), and we observed more new case of depressive symptoms or antidepressant 196 
consumption at 12 months in case of UI at 4 months.  197 
Studies using the EPDS found a score ≥ 13 in 7% to 17% of mothers between 6 weeks and 6 198 
months after childbirth (8,9,17). These results are similar to our findings (8.2–10.5%). Results for 199 
the mean EPDS score should be interpreted with caution because the mean score is not used in 200 
11 
clinical practice. The scale was developed to detect postnatal depression by using a cut-off between 201 
9 and 13 depending on the sensitivity and specificity expected.  202 
Postnatal UI prevalence is estimated between 6% and 21% and is often mild: in the cohort reported 203 
by Altman et al., the prevalence of stress UI was 21% at 5 months postpartum and occurred less 204 
than once a week for three quarters of women (18); for Viktrup et al., the UI prevalence was 6% at 205 
3 months postpartum and occurred daily for less than one quarter of women (1). In most cases, 206 
women are not bothered by postnatal urinary symptoms (19).  207 
In our longitudinal study, postnatal urinary incontinence reported at 4 months postpartum was 208 
followed by an increase in new depression or intake of psychotropic drugs 8 months later. Brown 209 
and Lumley interviewed 1336 women 6 to 7 months after giving birth: the risk of depression 210 
(EPDS ≥ 13) was multiplied by 2 with UI (8). Hullfish et al. interviewed 146 women 6 weeks after 211 
childbirth: the depression score (EPDS) was associated with the urge incontinence quality of life 212 
impact score (URGE-IIQ) but not urge incontinence symptoms (URGE-UDI) (9). In their 213 
longitudinal study, van de Pol et al. found a relationship between overactive bladder syndrome and 214 
depressive symptoms during pregnancy but not at 1 year postpartum (20). Mood disorders likely 215 
increase the impact of incontinence on quality of life. Depression is known to decrease health-216 
related quality of life (21). Depression may be a factor favouring the reporting or complaining of 217 
incontinence symptoms and happiness may favour ignoring or underreporting leakage. A cohort 218 
study of older women (mean 60 years old) showed that depression was associated with incident UI, 219 
but UI was not associated with incident depression (22).  220 
Although postnatal UI in our sample was often mild, it was associated with increased incidence of 221 
maternal depression or antidepressant use at 12 months postpartum. Thus, measuring the severity 222 
of incontinence (leakage frequency and quantity) captures only a part of the problem experienced 223 
by women. Clinicians need to be aware of the risk of depression associated with postnatal 224 
incontinence.  225 
226 
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 Table 1. De novo urinary incontinence at 4 months postpartum and severity by 
women’s characteristics. Chi² test. 
 De novo urinary incontinence at 4 months postpartum 
  No 
Yes,  
mild 
Yes, 
moderate 
 
Women’s characteristics 
N 
1413 
1215 
86.0% 
146 
10.3% 
52 
3.7% p value 
Age, years     
0.74 
< 25 203 85.7 9.8 4.4 
25–29 530 87.9 8.9 3.2 
30–34 471 84.7 11.7 3.6 
≥ 35 209 84.2 11.5 4.3 
Educational level     
0.21 
< High school diploma 355 85.9 9.6 4.5 
High school diploma 257 82.9 12.1 5.1 
University, first degree 319 84.0 11.9 4.1 
> University, first degree 460 88.9 8.9 2.2 
Occupational group     
0.04 
Managers, professionals 159 88.0 10.1 1.9 
Intermediate occupations 551 86.8 10.2 3.1 
Office or clerical workers, civil servants 324 82.7 13.3 4.0 
Shop, service, manual workers 276 87.0 9.1 4.0 
No paid occupation 82 85.4 4.9 9.8 
Marital status     
0.81 
Married couple 768 86.6 9.9 3.5 
Unmarried couple  565 85.1 11.2 3.7 
Single  72 86.1 8.3 5.6 
Body mass index, kg/m
2
     
0.14 
≤ 18.5  121 91.7 6.6 1.6 
18.5–25 917 86.4 9.9 3.7 
25–30 244 82.4 13.9 3.7 
≥ 30  105 83.8 9.5 6.7 
Parity     
0.88 
1 686 87.0 9.6 3.4 
2 504 85.3 10.7 4.0 
3 or more 221 84.6 11.3 4.1 
Highest birth weight, g     
0.79 < 4000 1295 86.0 10.3 3.7 
≥ 4000 113 85.8 11.5 2.7 
Delivery by     
0.31 Caesarean only 183 89.1 7.1 3.8 
Vaginal, at least one 1230 85.5 10.8 3.7 
Mode of last delivery     
0.24 
Caesarean 224 89.7 7.1 3.1 
Vaginal, spontaneous 1023 85.7 10.8 3.5 
Vaginal, instrumental 162 82.1 12.4 5.6 
Last active second phase of labour    
0.02 ≤ 30 min 1175 87.0 9.5 3.5 
> 30 min 203 79.8 15.8 4.4 
Breastfeeding     
0.77 
no 367 85.8 11.4 2.7 
1–10 weeks 309 86.7 9.4 3.9 
11–17 weeks 195 88.2 9.2 2.6 
Still breastfeeding at 4 months 437 85.1 10.5 4.4 
17 
 De novo urinary incontinence at 4 months postpartum 
  No 
Yes,  
mild 
Yes, 
moderate 
 
Women’s characteristics 
N 
1413 
1215 
86.0% 
146 
10.3% 
52 
3.7% p value 
Smoking during pregnancy     
0.55 yes 320 87.5 9.7 2.8 
no 1060 85.7 10.3 4.1 
Smoking at 4 months postpartum     
0.75 yes 313 87.2 9.6 3.2 
no 1098 85.6 10.6 3.8 
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Table 2. Risk factors of de novo urinary incontinence (UI) at 4 months postpartum. 
Polytomic logistic regression adjusted for centre.  
 
De novo urinary incontinence at 4 months postpartum 
Women’s characteristics 
No UI 
Yes, mild 
Adj OR (95% CI) 
Yes, moderate 
Adj OR (95% CI) p value 
Occupational group    
0.09 
Managers, professionals  1 1 1 
Intermediate occupations 1 1.02 (0.6–1.8) 1.50 (0.4–5.2) 
Office or clerical workers, civil servants 1 1.29 (0.7–2.4) 2.08 (0.6–7.5) 
Shop, service, manual workers 1 0.86 (0.4–1.7) 1.84 (0.5–6.9) 
No paid job 1 0.47 (0.1–1.5) 4.92 (1.2–19.4) 
Body mass index, kg/m
2
    
0.19 
≤ 18.5 1 0.62 (0.3–1.4) 0.38 (0.1–1.6) 
18.5–25 1 1 1 
25–30 1 1.55 (1.0–2.4) 0.86 (0.4–1.9) 
≥ 30 1 1.08 (0.5–2.2) 1.44 (0.6–3.6) 
Last active second phase of labour   
0.06 ≤ 30 min 1 1 1 
> 30 min 1 1.77 (1.1–2.9) 1.03 (0.4–2.3) 
Mode of last delivery    
0.42 
Caesarean 1 1 1 
Vaginal, spontaneous 1 1.51 (0.8–2.7) 1.00 (0.4–2.3) 
Vaginal, instrumental 1 1.42 (0.7–3.1) 1.78 (0.6–5.4) 
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Table 3. De novo urinary incontinence 4 months postpartum and depressive symptoms at 
4 and 12 months postpartum. Non-adjusted p values, and adjusted odds ratios for age, 
occupational group, marital status, parity, and centre. Analysis restricted to women who 
responded both questionnaires (4 and 12 months postpartum; N = 1226) 
 De novo urinary incontinence at 4 months postpartum  
 No Yes   
Depression indicators 
% (n/N), or 
mean (± sd) 
% (n/N), or 
mean (± sd) 
Non adjusted 
p value 
Adjusted OR 
(95% CI) 
4 months postpartum     
Depressive symptoms (EPDS ≥ 10) 15.9 (168/1054) 22.1 (38/172) 0.045 1.47 (0.98-2.21) 
Mean EPDS 4.84 (4.72) 6.25 (4.84) 0.001  
Antidepressant consumption 1.4 (15/1040) 4.7 (8/170) 0.005 3.13 (1.23-7.92) 
Depressive symptoms (EPDS≥ 10) 
or antidepressant consumption 
16.5 (172/1040) 25.3 (43/170) 0.006 1.67 (1.13-2.47) 
12 months postpartum     
Depressive symptoms (EPDS ≥ 10) 20.5 (216/1054) 24.4 (42/172) 0.242 1.18 (0.80-1.75) 
Mean EPDS 6.57 (3.72) 7.30 (3.46) 0.016  
Mean EPDS change between  
4 and 12 months postpartum 
+1.72 (4.45) +1.05 (4.45) 0.067  
Antidepressant consumption 2.8 (29/1048) 4.2 (7/166) 0.306 1.43 (0.61-3.37) 
Depressive symptoms (EPDS ≥ 10) 
or antidepressant consumption 
22.0 (228/1036) 28.9 (48/166) 0.049 1.37 (0.94-1.99) 
New cases of depressive symptoms or antidepressant consumption at 12 months postpartum ‡ 
Depressive symptoms (EPDS ≥ 10) 14.4 (128/886) 20.9 (28/134) 0.053 1.53 (0.96-2.43) 
Antidepressant consumption 1.5 (13/865) 1.6 (2/126) 0.928 0.85 (0.24-2.92) 
Depressive symptoms (EPDS ≥ 10) 
or antidepressant consumption 
15.3 (132/865) 23.8 (30/126) 0.012 1.70 (1.08-2.70) 
‡ New cases of depressive symptoms or antidepressant consumption among women not reporting 
depressive symptoms or taking antidepressant at 4 months postpartum 
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Table S1. Characteristics of excluded women from the analysis (Chi² test). 
 
Included women 
N=1413 
% 
Excluded women 
N=589 
% 
p 
Age, years    
less than 25 14.4 20.1 
<0.001 
25-29 37.5 28.5 
30-34 33.3 32.8 
35 or more 14.8 18.7 
Educational level   
<0.001 
< High school diploma 25.5 38.5 
High school diploma 18.5 16.6 
University, 1
st
 degree 22.9 18.2 
> University, 1
st
 degree 33.1 26.7 
Occupational group   
<0.001 
Managers, professionals 11.4 9.9 
Intermediate occupation 39.6 31.6 
Office or clerical workers, civil servants 23.3 18.6 
Shop, service, manual workers 19.8 32.7 
No paid occupation 5.9 7.1 
Marital status   
<0.001 Married couple 54.7 46.1 
Unmarried couple  40.2 44.0 
Single  5.1 9.9 
Parity   
<0.001 
0 48.6 32.9 
1 35.7 39.4 
2 11.7 18.9 
3 or more 4.0 8.7 
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Table S2. Characteristics of women who did not fill the 12 months questionnaire among those 
included in the analysis (Chi² test). 
 
Women without a 
follow-up at 12 
months postpartum 
N=177 
% 
Women with a 
follow-up at 12 
months postpartum 
N=1236 
% p 
Age, years N=177 N=1236  
less than 25 24.3 12.9 
0.0002 
25-29 39.0 37.3 
30-34 26.6 34.3 
35 or more 10.2 15.4 
Educational level N=175 N=1216  
< High school diploma 41.1 23.3 
<0.0001 
High school diploma 17.7 18.6 
University, 1
st
 degree 20.6 23.3 
> University, 1
st
 degree 20.6 34.9 
Occupational group N=176 N=1216  
Managers, professionals 6.2 12.2 
0.0005 
Intermediate occupations 31.2 40.8 
Office or clerical workers, civil servants 25.0 23.0 
Shop, service, manual workers 30.1 18.3 
Marital status N=175 N=1230  
Married couple 47.4 55.7 
0.0006 Unmarried couple  41.7 40.0 
Single  10.9 4.3 
Parity N=177 N=1236  
0 46.9 48.9 
0.389 
1 35.0 35.8 
2 15.2 11.2 
3 or more 2.8 4.1 
 
 
